Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
Moodys
Colorcon
AstraZeneca
Mallinckrodt

Last Updated: January 27, 2020

DrugPatentWatch Database Preview

Silver sulfadiazine - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic sources for silver sulfadiazine and what is the scope of freedom to operate?

Silver sulfadiazine is the generic ingredient in five branded drugs marketed by King Pharms Llc, Dr Reddys La, Thepharmanetwork Llc, and Franklin Pharms, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-two drug master file entries for silver sulfadiazine. Thirteen suppliers are listed for this compound.

Drug Prices for silver sulfadiazine

See drug prices for silver sulfadiazine

Drug Sales Revenue Trends for silver sulfadiazine

See drug sales revenues for silver sulfadiazine

Recent Clinical Trials for silver sulfadiazine

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Shanghai Yueyang Integrated Medicine HospitalPhase 2
SCARM Institute, Tabriz, IranPhase 2
Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do CearaPhase 2

See all silver sulfadiazine clinical trials

Recent Litigation for silver sulfadiazine

Identify potential future generic entrants

District Court Litigation
Case NameDate
ARGENTUM MEDICAL, LLC v. KAPPOS2010-07-09
Argentum Medical, LLC v. Noble Biomaterials2007-12-03

See all silver sulfadiazine litigation

Pharmacology for silver sulfadiazine
Medical Subject Heading (MeSH) Categories for silver sulfadiazine
Synonyms for silver sulfadiazine
(4-Amino-N-2-pyrimidinylbenzenesulfonamidato-NN,01)-silver
(4-Amino-N-pyrimidin-2-ylbenzenesulphonamidato-NN,O1)silver
[4-Amino-N-(2-pyrimidinyl-kN1)benzenesulfonamidato-kO]silver
22199-08-2
4-amino-N-(2-pyrimidinyl)benzenesulfonamide silver salr
4-Amino-N-(2-pyrimidinyl)benzenesulfonamide silver salt
4-Amino-n-(2-pyrimidyl)benzene-sulfonamide monosilver salt
4-Amino-N-2-pyrimidinylbenzenesulfonamide Silver Complex
AB0011467
AC-3535
AC1L9ATF
AC1L9Q6O
AC1NUR63
AK323659
AKOS005111099
ARONIS23842
AS-13863
Benzenesulfonamide, 4-amino-N-2-pyrimidinyl-, monosilver(1+) salt
C10H9AgN4O2S
CAS-22199-08-2
CHEBI:9142
CHEMBL1382627
CPD001906773
D00433
DB05245
Dermazin
Dermazine
dermazinr
DSSTox_CID_28572
DSSTox_GSID_48646
DSSTox_RID_82844
DTXSID4048646
EINECS 244-834-5
Flamazine
Flammazine
FT-0630481
Geben
geber
I06-0145
I06-145
J-014582
KS-00000H21
MFCD00072101 (97%)
MolPort-003-986-619
N(sup 1)-2-Pyrimidinylsulfanilamide monosilver(1+) salt
N1-2-Pyrimidinylsulfanilamide monosilver(1+) salt
NCGC00183137-01
NCGC00188438-01
NSC 625324
NSC625324
S0595
SAM002564255
SAM002699902
SC-17618
SCHEMBL15633
Silbertone
Sildaflo
Silvadene
Silvadene (TN)
silver (4-aminophenyl)sulfonyl-pyrimidin-2-yl-azanide
silver (4-aminophenyl)sulfonyl-pyrimidin-2-ylazanide
Silver (I) sulfadiazine, 98%
silver (I) sulfadiazinr
silver sulfadiazinate
Silver sulfadiazine, 98%
Silver sulphadiazine
Silver, (4-amino-N-2-pyrimidinylbenzenesulfonamidato-NN,O1)-
Silver, [4-amino-N-(2-pyrimidinyl-kN1)benzenesulfonamidato-kO]-
silver;(4-aminophenyl)sulfonyl-pyrimidin-2-ylazanide
silver(1+) [(4-aminophenyl)sulfonyl](pyrimidin-2-yl)azanide
silver(1+) ion 4-{[(pyrimidin-2-yl)azanidyl]sulfonyl}aniline
silver(1+) ion sulfadiazinate
silver(1+) sulfadiazinate
Silver(I) sulfadiazine
SSD
Sulfadiazin silber
Sulfadiazin, silbersalz
SULFADIAZINE SILVER
Sulfadiazine silver (JP17)
Sulfadiazine silver salt
Sulfadiazine, silver
Sulfadiazine, silver (USP)
Sulfadiazine, silver [USAN:USP]
Sulfanilamide, N(sup 1)-2-pyrimidinyl-, monosilver(1+) salt
SY105573
Thermazene
TL8001845
Tox21_112998
Tox21_113471
UNII-W46JY43EJR
W46JY43EJR
Paragraph IV (Patent) Challenges for SILVER SULFADIAZINE
Tradename Dosage Ingredient NDA Submissiondate
SILVADENE CREAM;TOPICAL silver sulfadiazine 017381

US Patents and Regulatory Information for silver sulfadiazine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys La SSD silver sulfadiazine CREAM;TOPICAL 018578-001 Feb 25, 1982 AB RX No No   Start Trial   Start Trial   Start Trial
Thepharmanetwork Llc THERMAZENE silver sulfadiazine CREAM;TOPICAL 018810-001 Dec 23, 1985 AB RX No No   Start Trial   Start Trial   Start Trial
King Pharms Llc SILVADENE silver sulfadiazine CREAM;TOPICAL 017381-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Dr Reddys La SSD AF silver sulfadiazine CREAM;TOPICAL 018578-003 Jul 11, 1990 DISCN No No   Start Trial   Start Trial   Start Trial
Franklin Pharms SILDAFLO silver sulfadiazine DRESSING;TOPICAL 019608-001 Nov 30, 1989 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for silver sulfadiazine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
King Pharms Llc SILVADENE silver sulfadiazine CREAM;TOPICAL 017381-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Franklin Pharms SILDAFLO silver sulfadiazine DRESSING;TOPICAL 019608-001 Nov 30, 1989   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
Boehringer Ingelheim
AstraZeneca
Mallinckrodt
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.